Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Decoy Therapeutics Inc. DCOY

Full chart Compare
Set alert

Price alert · DCOY

All alert types
1.11 USD +0.08 (+7.25%)

At closeNov 4, 2026, 7:02 AM EST

1.13 +0.02 +1.80%

Pre-market · Nov 4, 7:02 AM ET

1.04 Day range 1.12
0.90 52-week range 39.96
YTD
-85.75%
1 year
-97.44%

Financial health

Altman Z-Score

-20.11 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -0.3×
FY 2016: -26.1×FY 2017: -21.0×FY 2018: -3.4×FY 2019: -21.4×FY 2020: -23.1×FY 2021: -19.3×FY 2022: -1.2×FY 2023: -2.0×FY 2024: -3.8×FY 2025: -0.3×
FY 2016 5y median -2.0× FY 2025
P/S 0.0×
FY 2016: 1016×FY 2017: 567×FY 2018: 7.4×FY 2019: 42.8×FY 2020: 32.5×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.6×
FY 2016: 17.3×FY 2017: 24.8×FY 2018: 0.7×FY 2019: 14.0×FY 2020: 7.7×FY 2021: 6.4×FY 2022: 3.8×FY 2023: 4.8×FY 2024: 14.1×FY 2025: 0.6×
FY 2016 5y median 4.8× FY 2025
P/FCF -0.8×
FY 2016: -31.5×FY 2017: -26.0×FY 2018: -0.3×FY 2019: -12.8×FY 2020: -16.5×FY 2021: -24.1×FY 2022: -2.0×FY 2023: -2.0×FY 2024: -4.7×FY 2025: -0.8×
FY 2016 5y median -2.0× FY 2025
EV/EBITDA 0.6×
FY 2016: -25.3×FY 2017: -20.4×FY 2018: 0.2×FY 2019: -17.8×FY 2020: -21.0×FY 2021: -17.0×FY 2022: -1.2×FY 2023: -1.6×FY 2024: -3.4×FY 2025: 0.6×
FY 2016 5y median -1.6× FY 2025
EV/Sales 0.0×
FY 2016: 993×FY 2017: 552×FY 2018: -4.3×FY 2019: 41.8×FY 2020: 30.5×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -128.7%
FY 2016: -3.2%FY 2017: -3.9%FY 2018: -378.4%FY 2019: -7.8%FY 2020: -6.1%FY 2021: -4.1%FY 2022: -49.0%FY 2023: -50.4%FY 2024: -21.3%FY 2025: -128.7%
FY 2016 5y median -49.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 34.4%FY 2017: 60.3%FY 2018: 48.6%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -3946.5%FY 2017: -2724.6%FY 2018: -2633.7%FY 2019: -238.5%FY 2020: -148.8%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -3907.6%FY 2017: -2701.7%FY 2018: -2615.6%FY 2019: -200.2%FY 2020: -140.5%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -212.6%
FY 2016: -66.6%FY 2017: -118.3%FY 2018: -236.2%FY 2019: -65.6%FY 2020: -33.2%FY 2021: -33.0%FY 2022: -304.4%FY 2023: -237.2%FY 2024: -368.8%FY 2025: -212.6%
FY 2016 5y median -237.2% FY 2025
ROIC -214.2%
FY 2016: -67.2%FY 2017: -119.1%FY 2018: -410.8%FY 2019: -74.6%FY 2020: -34.4%FY 2021: -33.1%FY 2022: -306.6%FY 2023: -231.2%FY 2024: -330.8%FY 2025: -214.2%
FY 2016 5y median -231.2% FY 2025
ROA -113.2%
FY 2016: -62.5%FY 2017: -98.4%FY 2018: -211.0%FY 2019: -49.9%FY 2020: -29.5%FY 2021: -31.3%FY 2022: -215.7%FY 2023: -190.4%FY 2024: -184.4%FY 2025: -113.2%
FY 2016 5y median -184.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 26.1%FY 2018: -34.2%FY 2019: 313.4%FY 2020: 51.0%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -120.0%
FY 2016: -36.5%FY 2017: 12.9%FY 2018: 36.4%FY 2019: 62.6%FY 2020: 5.8%FY 2021: -64.6%FY 2022: -148.5%FY 2023: 59.5%FY 2024: 55.5%FY 2025: -120.0%
FY 2016 FY 2025
EPS (diluted) 70.1%
FY 2016: -16.8%FY 2017: 18.1%FY 2018: 41.5%FY 2019: 92.7%FY 2020: 77.8%FY 2021: 34.6%FY 2022: -92.8%FY 2023: 74.2%FY 2024: 81.1%FY 2025: 70.1%
FY 2016 FY 2025
Free Cash Flow -6.7%
FY 2016: -55.2%FY 2017: 14.6%FY 2018: 15.2%FY 2019: 50.9%FY 2020: 10.9%FY 2021: 1.1%FY 2022: -87.2%FY 2023: 32.7%FY 2024: 64.8%FY 2025: -6.7%
FY 2016 FY 2025

Financial Health

Current Ratio 2.1×
FY 2016: 16.1×FY 2017: 5.9×FY 2018: 2.1×FY 2019: 1.4×FY 2020: 5.7×FY 2021: 14.3×FY 2022: 3.4×FY 2023: 5.0×FY 2024: 2.0×FY 2025: 2.1×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 2.1×
FY 2016: 15.9×FY 2017: 5.8×FY 2018: 2.0×FY 2019: 1.4×FY 2020: 5.7×FY 2021: 14.3×FY 2022: 3.4×FY 2023: 5.0×FY 2024: 2.0×FY 2025: 2.1×
FY 2016 5y median 3.4× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2016: 0.6×FY 2017: 0.6×FY 2018: 0.4×FY 2019: 0.4×FY 2020: 1.4×FY 2021: 2.3×FY 2022: 0.5×FY 2023: 0.4×FY 2024: 0.4×FY 2025: 0.9×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -2555×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.1%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -1.9%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31